Suvi Syväranta

568 total citations
16 papers, 411 citations indexed

About

Suvi Syväranta is a scholar working on Cardiology and Cardiovascular Medicine, Cancer Research and Surgery. According to data from OpenAlex, Suvi Syväranta has authored 16 papers receiving a total of 411 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cardiology and Cardiovascular Medicine, 5 papers in Cancer Research and 4 papers in Surgery. Recurrent topics in Suvi Syväranta's work include Cardiac Valve Diseases and Treatments (6 papers), Protease and Inhibitor Mechanisms (4 papers) and Cardiac Imaging and Diagnostics (3 papers). Suvi Syväranta is often cited by papers focused on Cardiac Valve Diseases and Treatments (6 papers), Protease and Inhibitor Mechanisms (4 papers) and Cardiac Imaging and Diagnostics (3 papers). Suvi Syväranta collaborates with scholars based in Finland and United States. Suvi Syväranta's co-authors include Petri T. Kovanen, Markku Kupari, Satu Helske, Jani Lappalainen, Ken A. Lindstedt, Mikko I. Mäyränpää, Jyri Lommi, Heikki Turto, Kalervo Werkkala and Mika Laine and has published in prestigious journals such as PLoS ONE, European Heart Journal and Arteriosclerosis Thrombosis and Vascular Biology.

In The Last Decade

Suvi Syväranta

16 papers receiving 404 citations

Peers

Suvi Syväranta

CCM

PRM

EPIDE

IMMUN

Hanna M. Björck Sweden

Maged F. Nageh United States

Toshiyuki Okuma Japan

Fayez Hadji Canada

Sander M. van de Weg Netherlands

Jeffrey R. Crawford United States

Iván Parra‐Izquierdo United States

Nadjim Chelghoum France

Azumi Hamasaki Japan

Rui‐Yi Lu China

Hanna M. Björck Sweden

Suvi Syväranta

181 ×0.7

CCM

189 ×1.4

PRM

36 ×0.4

EPIDE

116 ×1.4

41 ×0.5

IMMUN

Citations per year, relative to Suvi Syväranta Suvi Syväranta (= 1×) peers Hanna M. Björck

Countries citing papers authored by Suvi Syväranta

Since Specialization

Citations

This map shows the geographic impact of Suvi Syväranta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suvi Syväranta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suvi Syväranta more than expected).

Fields of papers citing papers by Suvi Syväranta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suvi Syväranta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suvi Syväranta. The network helps show where Suvi Syväranta may publish in the future.

Co-authorship network of co-authors of Suvi Syväranta

This figure shows the co-authorship network connecting the top 25 collaborators of Suvi Syväranta. A scholar is included among the top collaborators of Suvi Syväranta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suvi Syväranta. Suvi Syväranta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Mäkelä, Teemu, et al.. (2024). Testing process for artificial intelligence applications in radiology practice. Physica Medica. 128. 104842–104842. 4 indexed citations

Pöyhönen, Pauli, Jukka Lehtonen, Suvi Syväranta, et al.. (2024). Magnetic Resonance Imaging in the Assessment of the Risk of Sudden Death in Cardiac Sarcoidosis: What Is Extensive or Significant Late Gadolinium Enhancement?. Circulation Arrhythmia and Electrophysiology. 18(1). e013239–e013239. 6 indexed citations

Rajala, Helena, et al.. (2023). Impact of Atrial Fibrillation on the Symptoms and Echocardiographic Evaluation of Patients With Aortic Stenosis. The American Journal of Cardiology. 211. 122–129. 3 indexed citations

Pöyhönen, Pauli, Hanna‐Kaisa Nordenswan, Jukka Lehtonen, et al.. (2023). Cardiac magnetic resonance in giant cell myocarditis: a matched comparison with cardiac sarcoidosis. European Heart Journal - Cardiovascular Imaging. 24(4). 404–412. 17 indexed citations

Uusitalo, Valtteri, Miia Holmström, Tiina Heliö, et al.. (2023). Cardiac magnetic resonance -detected myocardial injury is not associated with long-term symptoms in patients hospitalized due to COVID-19. PLoS ONE. 18(3). e0282394–e0282394. 7 indexed citations

Syväranta, Suvi, Suvi Tuohinen, Miia Holmström, et al.. (2023). Myocardial T1 mapping by cardiac magnetic resonance imaging shows early myocardial changes in treatment-naive patients with active rheumatoid arthritis and positive autoantibodies. Clinical and Experimental Rheumatology. 42(7). 1368–1376. 1 indexed citations

Uusitalo, Valtteri, et al.. (2023). Safe Deferral of Coronary Computed Tomography Angiography for Patients With a Low Pretest Probability of Coronary Artery Disease in 2019 European Society of Cardiology Guidelines. Journal of the American Heart Association. 12(23). e029933–e029933. 2 indexed citations

Kaasalainen, Touko, Miia Holmström, Jyri Lommi, et al.. (2021). Peak flow measurements in patients with severe aortic stenosis: a prospective comparative study between cardiovascular magnetic resonance 2D and 4D flow and transthoracic echocardiography. Journal of Cardiovascular Magnetic Resonance. 23(1). 132–132. 12 indexed citations

Ohukainen, Pauli, Suvi Syväranta, Juha Näpänkangas, et al.. (2015). MicroRNA-125b and chemokine CCL4 expression are associated with calcific aortic valve disease. Annals of Medicine. 47(5). 423–429. 55 indexed citations

10.

Syväranta, Suvi, Mervi Alanne-Kinnunen, Katariina Öörni, et al.. (2014). Potential pathological roles for oxidized low-density lipoprotein and scavenger receptors SR-AI, CD36, and LOX-1 in aortic valve stenosis. Atherosclerosis. 235(2). 398–407. 39 indexed citations

11.

Syväranta, Suvi. (2013). MECHANISMS OF ANGIOGENESISAND LYMPHANGIOGENESIS. 1 indexed citations

12.

Syväranta, Suvi, Satu Helske, Jani Lappalainen, Markku Kupari, & Petri T. Kovanen. (2011). Lymphangiogenesis in aortic valve stenosis—Novel regulatory roles for valvular myofibroblasts and mast cells. Atherosclerosis. 221(2). 366–374. 27 indexed citations

13.

Syväranta, Suvi, Satu Helske, Mika Laine, et al.. (2010). Vascular Endothelial Growth Factor–Secreting Mast Cells and Myofibroblasts. Arteriosclerosis Thrombosis and Vascular Biology. 30(6). 1220–1227. 52 indexed citations

14.

Helske, Satu, Suvi Syväranta, Markku Kupari, et al.. (2006). Possible role for mast cell-derived cathepsin G in the adverse remodelling of stenotic aortic valves. European Heart Journal. 27(12). 1495–1504. 99 indexed citations

15.

Helske, Satu, Suvi Syväranta, Ken A. Lindstedt, et al.. (2006). Increased Expression of Elastolytic Cathepsins S, K, and V and Their Inhibitor Cystatin C in Stenotic Aortic Valves. Arteriosclerosis Thrombosis and Vascular Biology. 26(8). 1791–1798. 82 indexed citations

16.

Helske, Satu, Suvi Syväranta, K.A. Lindstedt, et al.. (2006). Tu-P7:264 Increased expression of elastolytic cathepsins S, K, and V, and their inhibitor cystatin C in stenotic aortic valves. Atherosclerosis Supplements. 7(3). 242–243. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact